Devyser enters agreement with Illumina to offer sequencing instruments and products
Agreement with Illumina brings industry-leading sequencing platforms together with Devyser’s validated genetic testing solutions
Agreement with Illumina brings industry-leading sequencing platforms together with Devyser’s validated genetic testing solutions
In this guest editorial, Dr. Wubin Qu, CSO and Co-Founder of iGeneTech, offers perspective on changing NGS workflows vs changing capture kit reagents
Reimagining clinical microbiology with key technologies and long-acting therapies
Dr. Lauren Murphy at the University of Oxford is investigating how platelets could hold the key to detecting cancer in patients with minimal residual disease
New compact analyzer combines 5-part extended DIFF with rapid CRP whole blood measurement, delivering clinically relevant information for enhanced diagnoses in laboratory settings
Accuracy in ESR1 mutation testing means the difference between treatment and resistance — now a new ESR1 control kit ensures reliable results
President of Diagnostic Solutions at Hologic explains how adopting advanced molecular‑diagnostic technologies is for labs of the future
In this guest editorial, Daniel Monteiro discusses his everyday life in the lab, balancing laboratory science, clinical collaboration, training, and service development.
In this SelectScience webinar, experts explain how defining total allowable error and applying sigma metrics can guide smarter QC decisions and streamline laboratory workflows
Registry developed to advance real-world evidence in treatment outcomes
New laboratory tools are prompting a rethink of how intrathecal inflammation is assessed beyond oligoclonal bands
New, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity will be available in the UK within the next few weeks
Thermo Fisher Scientific launches Registry to advance real-world evidence in neurodegenerative care
DNA-free nucleic acid isolation kits streamline molecular diagnostics, improving sensitivity, speed, and automation for early diagnosis and monitoring
Discover how automation enhances accuracy and efficiency of liquid biopsy workflows, paving the way for advancements in personalized medicine and improved patient care
Froedtert Hospital results reinforce growing real-world evidence that IntelliSep is a transformative tool for suspected infections in emergency departments
The fully automated solution replaces labor-intensive manual workflows, reducing turnaround times and supporting faster, standardized, high-quality care
Find out why millions of cases of hepatitis B and C are going undiagnosed and how clinical labs could play an important role in getting more people tested and treated
Leading experts reveal how laboratory biomarkers are transforming emergency and long-term cardiac care around the world
Simoa HD-X receives MFDS Class I IVD Import Clearance, enabling the first clinical introduction of Simoa technology in Korea
The new subsidiary is expected to accelerate broader adoption of Seegene’s developing solutions, CURECA™ and STAgora™, in Europe
Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape
The new PCR test aids in the diagnosis of infectious causes of vaginitis through the detection of bacteria associated with bacterial vaginosis and yeast associated with candida vaginitis
Experts discuss the evolving landscape of clinical mass spectrometry, the impact of automation, challenges in integration, and what the future holds